When the chair-CEO relationship needs clearer operating rules
Clarifying cadence, decision rights, escalation, challenge and support so the relationship sharpens execution rather than adding friction.
Advisory
LB Strategy works where governance becomes strategic: board design, chair-CEO alignment, private-company governance maturity, investor-founder dynamics, AI oversight and MedTech scale.
Where useful
Clarifying cadence, decision rights, escalation, challenge and support so the relationship sharpens execution rather than adding friction.
Moving private and growth companies from instinctive oversight to board structures that improve decisions without slowing the company down.
Sharpening agenda design, board packs, committee rhythm, information quality and follow-through so meetings produce judgement, not theatre.
Rebuilding alignment around value creation, risk, capital and strategic choices — and the role of independent board judgement.
Turning AI risk and opportunity into board-level questions on accountability, data, models, controls, ethics and resilience.
Supporting boards through regulation, reimbursement, evidence generation, clinical adoption, commercial execution and patient impact.
Representative situations
The work is tailored, but these are recurring situations where sharper governance architecture matters.
How it works
LB Strategy is designed for boards and leadership teams that need a more disciplined operating rhythm, not a consultant performance.
Discretion
Current board appointments and confidential advisory work are not listed publicly.
Start a confidential conversation